Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Progesterone luteal-phase support during expectant management for unexplained infertility
NL-OMON61313Phase 4Not yet recruiting
- Sponsor
- University Medical Center Utrecht
- Start
- Jul 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in Unexplained infertility comparing Micronized progesterone luteal-phase support with Placebo (2 arms). Primary endpoint: Live birth within 6 months after randomization. Planned start Jul 2026; status: not yet recruiting.
02
Drugs
progesterone
03
Conditions
Unexplained infertility
Beyond the preview
Go deeper on NL-OMON61313.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON61313.